Long-Term Management of Post-Stroke Spasticity with Botulinum Toxin: A Retrospective Study.

ABSTRACT: Stroke-induced spasticity is a prevalent condition affecting stroke survivors, significantly impacting their quality of life. Botulinum Toxin A injections are widely used for its management, yet the long-term effects and optimal management strategies remain uncertain. This retrospective study analyzed medical records of 95 chronic stroke patients undergoing long-term BoNT-A treatment for spasticity. Demographic data, treatment duration, dosage variability, and dropout rates were assessed over a period ranging from 2 to 14 years. The study revealed a notable extension of the interval between BoNT-A injections throughout the treatment duration. Dropout rates peaked during the initial 5 years of treatment, perhaps due to perceived treatment ineffectiveness. Additionally, a trend of escalating

SUBMITTER: Falcone N 

PROVIDER: S-EPMC11436082 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature